It is the most frequently co-mutated gene in EGFR-mutated aNSCLC (up to 72%) [28], and dysfunction of the p53 protein due to mutations contributes to tumor development, progression, and metastasis [27]. This evidence concerns the gene EGFR and neoplasm.